by | Jul 13, 2020 | Ory, Daniel, Peterson, Linda, Schaffer, Jean
— Technology Description
A team of researchers has developed a high throughput, FDA-compliant assay to predict coronary heart disease and mortality in the general population 6-10 years before the onset of disease. This fully validated two-dimensional liquid chromatography-tandem mass spectrometry (L…
by | Jun 9, 2020 | Chaudhuri, Aadel, Maher, Christopher, Pachynski, Russell
— Technology Description
A team of researchers at Washington University has developed “EnhanceAR-Seq”, a circulating tumor DNA (ctDNA) assay that predicts which patients are at high risk for developing resistance to androgen receptor (AR)-directed treatment for metastatic prostate cancer…
by | May 26, 2020 | Chu, Wenhua, Zhou, Dong
— Technology Description
Researchers at Washington University in St. Louis (WUSTL) have developed a new method and device for the preparation of flourine-18 (F-18) radiolabeled compounds as positron emission tomography (PET) tracers. PET is a widely used clinical and research imaging tool that will …
by | May 26, 2020 | Zhou, Dong
— Technology Description
Researchers at Washington University in St. Louis (WUSTL) have developed a new method and device for the preparation of flourine-18 (F-18) radiolabeled compounds as positron emission tomography (PET) tracers. PET is a widely used clinical and research imaging tool that will …
by | Apr 8, 2020 | Andleeb, Saadia, Burnham, Carey-Ann
— Superficieibacter electus